Active Shortage Injection Anesthesia

Epinephrine Bitartrate, Lido · #3 of 35 active shortages by FDA posting duration

Brand: XYLOCAINE MPF

FDA lists Epinephrine Bitartrate, Lido as Active Shortage (Fresenius Kabi USA, LLC).

Availability on file: Unavailable

Epinephrine Bitartrate, Lidocaine Hydrochloride Injection: Active Shortage

Unavailable 24 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.

Shortage Details

Generic Name
Epinephrine Bitartrate, Lidocaine Hydrochloride Injection
Manufacturer
Fresenius Kabi USA, LLC
Dosage Form
Injection
Presentation
Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-17)
Package NDC
63323-487-17

Status & Timeline

Status
Active Shortage
Availability
Unavailable
First Reported
Oct 14, 2016
Last Updated
Mar 17, 2026
Therapeutic Category
Anesthesia, Pediatric

Row fields from the FDA Drug Shortages database via openFDA.

Shortage Reason

Next release March 2026. Check wholesalers for inventory.

Full Drug Profile

epinephrine

Side effects, interactions, warnings & more

View Profile
Compare epinephrine with alternatives →

Nearby, Other Epinephrine Shortage Records

Epinephrine Bitartrate, Lidocaine Hydrochloride Injection

Fresenius Kabi USA, LLC

Injection

Active Shortage

Epinephrine Bitartrate, Lidocaine Hydrochloride Injection

Fresenius Kabi USA, LLC

Injection

Active Shortage

Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection

Fresenius Kabi USA, LLC

Injection

Active Shortage

Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection

Fresenius Kabi USA, LLC

Injection

Active Shortage

Epinephrine Bitartrate, Lidocaine Hydrochloride Injection

Fresenius Kabi USA, LLC

Injection

Active Shortage

Epinephrine Bitartrate, Lidocaine Hydrochloride Injection

Fresenius Kabi USA, LLC

Injection

Active Shortage

FDA reason on file: Next release March 2026. General shortage guidance lives on the tracker hub.

← All Drug Shortages